Denmark: DanCann Pharma goes direct to write down debt

DanCann Pharma, a biopharmaceutical company developing new therapeutic cannabinoids, has decided on a new share issue of up to 2,031,250 shares at a subscription price of DKK0.63 (US$0.09) per share to raise a total of SEK2m (US$190,000). Capital raised will be used to reduce debt. The subscription price corresponds to the VWAP for the share…

You must be a HMI Subscriber to view this content.

Subscribe Now »